Alendronate Sodium
Product Images NDC 21695-902

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Alendronate Sodium (NDC 21695-902). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fosamax_structure (Eb668bf3 Aab0 4529 Bf8f E740a5d5f3b8 01)

Fosamax_structure (Eb668bf3 Aab0 4529 Bf8f E740a5d5f3b8 01)
Chemical structure diagram of alendronate sodium trihydrate, showing the molecular bonds and arrangement of atoms including phosphorus, oxygen, sodium, carbon, and nitrogen.*
FDA Label Image

Figure (Eb668bf3 Aab0 4529 Bf8f E740a5d5f3b8 02)

Figure (Eb668bf3 Aab0 4529 Bf8f E740a5d5f3b8 02)
A bar chart comparing the mean percentage increase in bone mineral density (BMD) relative to placebo plus standard error (SE) at the lumbar spine, femoral neck, and trochanter. It displays results for two groups labeled U.S. and Multinational, showing higher BMD increase in the U.S. group across all bone sites.*
FDA Label Image

Figure (Eb668bf3 Aab0 4529 Bf8f E740a5d5f3b8 03)

Figure (Eb668bf3 Aab0 4529 Bf8f E740a5d5f3b8 03)
The image contains two line graphs comparing bone mineral density (BMD) percent change from baseline over 36 months between Alendronate Sodium 10 mg and placebo groups. The left graph shows data from a U.S. study, and the right graph from a multinational study, both depicting BMD improvements with Alendronate Sodium versus placebo over time.*
FDA Label Image

Figure (Eb668bf3 Aab0 4529 Bf8f E740a5d5f3b8 04)

Figure (Eb668bf3 Aab0 4529 Bf8f E740a5d5f3b8 04)
A line chart comparing cumulative incidence (%) over time (months) for Alendronate Sodium and Placebo groups over a 36-month period. The chart shows the progression of cumulative incidence for both groups, with Alendronate Sodium represented by a solid line and Placebo by a dashed line.*
FDA Label Image

Figure (Eb668bf3 Aab0 4529 Bf8f E740a5d5f3b8 05)

Figure (Eb668bf3 Aab0 4529 Bf8f E740a5d5f3b8 05)
Two bar charts illustrating the change in Bone Mineral Density (BMD) from baseline in a 2-year and 3-year study. Both charts compare the effects of Alendronate Sodium 5 mg/day versus placebo on various body regions: Lumbar Spine, Femoral Neck, Trochanter, and Total Body, showing mean percentage changes with standard error.*
FDA Label Image

Figure (Eb668bf3 Aab0 4529 Bf8f E740a5d5f3b8 06)

Figure (Eb668bf3 Aab0 4529 Bf8f E740a5d5f3b8 06)
A bar chart comparing the mean percentage increase in Bone Mineral Density (BMD) at three sites: Lumbar Spine, Femoral Neck, and Trochanter. It shows data for two groups labeled U.S. and Multinational, with associated error bars representing standard error of the mean. The vertical axis measures BMD increase relative to placebo.*
FDA Label Image

Figure (Eb668bf3 Aab0 4529 Bf8f E740a5d5f3b8 07)

Figure (Eb668bf3 Aab0 4529 Bf8f E740a5d5f3b8 07)
A line graph showing the mean percentage change from baseline in serum alkaline phosphatase over six months. Four groups are compared: Placebo (circles), Etidronate 400 mg/day (squares), Alendronate Sodium 40 mg/day from a multinational study (down triangles), and Alendronate Sodium 40 mg/day from a U.S. study (up triangles). Data points are plotted at 0, 3, and 6 months with error bars representing the standard error.*
FDA Label Image

Alendronate Sodium 35mg (Eb668bf3 Aab0 4529 Bf8f E740a5d5f3b8 08)

Alendronate Sodium 35mg (Eb668bf3 Aab0 4529 Bf8f E740a5d5f3b8 08)
Alendronate Sodium 35 mg tablet label from Physician Partner. The label indicates a package of 4 tablets for once-weekly use. It states each tablet contains 45.68 mg alendronate sodium (35 mg free acid equivalent). Distributed by Physician Partner, Thousand Oaks, CA, with storage instructions and a product ID RA090104.*
FDA Label Image

Alendronate Sodium 70mg (Eb668bf3 Aab0 4529 Bf8f E740a5d5f3b8 09)

Alendronate Sodium 70mg (Eb668bf3 Aab0 4529 Bf8f E740a5d5f3b8 09)
Alendronate Sodium 70 mg tablets packaging label showing a count of 4 tablets, with a note indicating once weekly dosing. The label includes active ingredient details, lot and expiration information, and is distributed by Physician Partner. Storage instructions specify controlled room temperature. The label also features barcodes and cautions for RX only and child safety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.